Pharmaceutical Industry in
Nyon

EFFIK SA

Since 2006 · 11–20 empl.

EFFIK SA is a pharmaceutical company specializing in the development, manufacture, and distribution of medicines, medical devices, and dietary supplements. The company's core activities include: * Research and development of new therapies and products, particularly in the fields of gynecology, neurology, hematology, and cardiology * Manufacturing and distribution of medicines, medical devices, and dietary supplements * Development of solutions for specific patient groups, such as women in various life situations (e.g. pregnancy, menopause) * Collaboration with medical experts and physicians to develop innovative solutions and improve patient care The company focuses on developing products tailored to the specific needs of patients and healthcare providers, and values quality, innovation, and patient proximity.

HRA-Pharma Switzerland Sàrl

Since 2009 · 1–10 empl.

HRA-Pharma Switzerland Sàrl is a company active in self-care and consumer health products. The website presents products and solutions for conditions that can be self-managed or prevented, including areas such as cold and respiratory care, pain relief, skincare, oral care and women's health.

Hartis-Pharma SA

Since 2016 · 11–20 empl.

The core activity of HARTIS Pharma consists of researching and developing therapeutics based on the potential benefits of High-Density-Lipoprotein (HDL), particularly through the regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants. The company focuses on developing treatments for medical needs that have not been adequately addressed or cannot be treated sufficiently.

Swiss Medical Cannabis SA

Since 2017 · 11–20 empl.

Swiss Medical Cannabis SA sells hemp and cannabis products through an online shop and supplies these products via pharmacies and other retail partners.

Bial SA

Since 2018 · 21–50 empl.

The core activity of BIAL is the development, manufacture and marketing of medicines and therapeutic solutions in the healthcare sector. The company focuses particularly on research and development of new medicines and therapies to improve the quality of life of people worldwide.

Horus Pharma Suisse SA

Since 2021 · 101–500 empl.

The core activity of Horus Pharma is the development, manufacture and marketing of pharmaceuticals, medical devices and dietary supplements, particularly in the fields of ophthalmology, dermatology and surgery. The company focuses on creating therapeutic solutions and accompanying services for doctors and patients, with an emphasis on innovation, ethics and patient benefit.

NOVIPHARMA SA

Since 2005 · 1–10 empl.

NOVIPHARMA SA manages the global supply chain for innovative medicines developed through Bial’s research and development activities. The company serves as Bial’s strategic platform for worldwide growth and is authorised by Swissmedic for wholesale and foreign trade of drugs.

Société anonyme de Marques

Since 1947 · 1–10 empl.

Horus Pharma International SA

Since 2006 · 1–10 empl.

Lyneline Sàrl

Since 2019 · 1–10 empl.

EVIR Therapeutics SA

Since 2020 · 1–10 empl.

InGen Sàrl

Since 2021 · 1–10 empl.